-
1
-
-
84902866929
-
-
World Cancer Research Fund International
-
World Cancer Research Fund International http://www.wcrf.org/cancer- statistics/data-specific-cancers/index.php, 2014.
-
(2014)
-
-
-
2
-
-
66149133290
-
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence
-
Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M,. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009; 125: 171-80.
-
(2009)
Int J Cancer
, vol.125
, pp. 171-180
-
-
Huxley, R.R.1
Ansary-Moghaddam, A.2
Clifton, P.3
Czernichow, S.4
Parr, C.L.5
Woodward, M.6
-
3
-
-
84873026456
-
The role of anti-inflammatory drugs in colorectal cancer
-
Wang D, DuBois RN,. The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med 2013; 64: 131-44.
-
(2013)
Annu Rev Med
, vol.64
, pp. 131-144
-
-
Wang, D.1
Dubois, R.N.2
-
4
-
-
34248157118
-
Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies
-
Flossmann E, Rothwell PM,. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-13.
-
(2007)
Lancet
, vol.369
, pp. 1603-1613
-
-
Flossmann, E.1
Rothwell, P.M.2
-
5
-
-
84855556537
-
Aspirin in the chemoprevention of colorectal neoplasia: An overview
-
Chan AT, Arber N, Burn J, et al,. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) 2012; 5: 164-78.
-
(2012)
Cancer Prev Res (Phila)
, vol.5
, pp. 164-178
-
-
Chan, A.T.1
Arber, N.2
Burn, J.3
-
6
-
-
84896737676
-
Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-The science
-
Sahin IH, Hassan MM, Garrett CR,. Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science. Cancer Lett 2014; 345: 249-57.
-
(2014)
Cancer Lett
, vol.345
, pp. 249-257
-
-
Sahin, I.H.1
Hassan, M.M.2
Garrett, C.R.3
-
7
-
-
77649179672
-
Eicosanoids and cancer
-
Wang D, DuBois RN,. Eicosanoids and cancer. Nat Rev Cancer 2010; 10: 181-93.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 181-193
-
-
Wang, D.1
Dubois, R.N.2
-
8
-
-
84867491632
-
Clinical pharmacology of non-steroidal anti-inflammatory drugs: A review
-
Bacchi S, Palumbo P, Sponta A, Coppolino MF,. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem 2012; 11: 52-64.
-
(2012)
Antiinflamm Antiallergy Agents Med Chem
, vol.11
, pp. 52-64
-
-
Bacchi, S.1
Palumbo, P.2
Sponta, A.3
Coppolino, M.F.4
-
9
-
-
0029035070
-
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
-
Piazza GA, Rahm AL, Krutzsch M, et al,. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995; 55: 3110-6.
-
(1995)
Cancer Res
, vol.55
, pp. 3110-3116
-
-
Piazza, G.A.1
Rahm, A.L.2
Krutzsch, M.3
-
10
-
-
84055190414
-
The crosstalk of PTGS2 and EGF signaling pathways in colorectal cancer
-
Wang D, Xia D, DuBois RN,. The crosstalk of PTGS2 and EGF signaling pathways in colorectal cancer. Cancers (Basel) 2011; 3: 3894-908.
-
(2011)
Cancers (Basel)
, vol.3
, pp. 3894-3908
-
-
Wang, D.1
Xia, D.2
Dubois, R.N.3
-
11
-
-
84886794476
-
NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer
-
Vaish V, Piplani H, Rana C, Vaiphei K, Sanyal SN,. NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer. Mol Cell Biochem 2013; 378: 47-64.
-
(2013)
Mol Cell Biochem
, vol.378
, pp. 47-64
-
-
Vaish, V.1
Piplani, H.2
Rana, C.3
Vaiphei, K.4
Sanyal, S.N.5
-
12
-
-
84873413504
-
The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer
-
Wang X, Baek SJ, Eling TE,. The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer. Biochem Pharmacol 2013; 85: 597-606.
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 597-606
-
-
Wang, X.1
Baek, S.J.2
Eling, T.E.3
-
13
-
-
84867085932
-
New NSAID targets and derivatives for colorectal cancer chemoprevention
-
Tinsley HN, Grizzle WE, Abadi A, et al,. New NSAID targets and derivatives for colorectal cancer chemoprevention. Recent Results Cancer Res 2013; 191: 105-20.
-
(2013)
Recent Results Cancer Res
, vol.191
, pp. 105-120
-
-
Tinsley, H.N.1
Grizzle, W.E.2
Abadi, A.3
-
14
-
-
73249122912
-
Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study
-
Andersen V, Ostergaard M, Christensen J, Overvad K, Tjonneland A, Vogel U,. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 2009; 9: 407.
-
(2009)
BMC Cancer
, vol.9
, pp. 407
-
-
Andersen, V.1
Ostergaard, M.2
Christensen, J.3
Overvad, K.4
Tjonneland, A.5
Vogel, U.6
-
15
-
-
77956483124
-
Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes
-
Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U,. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010; 10: 484.
-
(2010)
BMC Cancer
, vol.10
, pp. 484
-
-
Andersen, V.1
Christensen, J.2
Overvad, K.3
Tjonneland, A.4
Vogel, U.5
-
16
-
-
84872699097
-
Systematic review: Diet-gene interactions and the risk of colorectal cancer
-
Andersen V, Holst R, Vogel U,. Systematic review: diet-gene interactions and the risk of colorectal cancer. Aliment Pharmacol Ther 2013; 37: 383-91.
-
(2013)
Aliment Pharmacol Ther
, vol.37
, pp. 383-391
-
-
Andersen, V.1
Holst, R.2
Vogel, U.3
-
17
-
-
84861079657
-
Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a Danish case-cohort study
-
Andersen V, Egeberg R, Tjonneland A, Vogel U,. Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a Danish case-cohort study. BMC Cancer 2012; 12: 183.
-
(2012)
BMC Cancer
, vol.12
, pp. 183
-
-
Andersen, V.1
Egeberg, R.2
Tjonneland, A.3
Vogel, U.4
-
18
-
-
84859563860
-
ABCC2 transporter gene polymorphisms, diet and risk of colorectal cancer: A Danish prospective cohort study
-
Andersen V, Egeberg R, Tjonneland A, Vogel U,. ABCC2 transporter gene polymorphisms, diet and risk of colorectal cancer: a Danish prospective cohort study. Scand J Gastroenterol 2012; 47: 572-4.
-
(2012)
Scand J Gastroenterol
, vol.47
, pp. 572-574
-
-
Andersen, V.1
Egeberg, R.2
Tjonneland, A.3
Vogel, U.4
-
19
-
-
84886036425
-
Interactions between Diet, Lifestyle and IL10, IL1B, and PTGS2/COX-2 Gene Polymorphisms in Relation to Risk of Colorectal Cancer in a Prospective Danish Case-Cohort Study
-
Andersen V, Holst R, Kopp TI, Tjonneland A, Vogel U,. Interactions between Diet, Lifestyle and IL10, IL1B, and PTGS2/COX-2 Gene Polymorphisms in Relation to Risk of Colorectal Cancer in a Prospective Danish Case-Cohort Study. PLoS ONE 2013; 8: e78366.
-
(2013)
PLoS ONE
, vol.8
-
-
Andersen, V.1
Holst, R.2
Kopp, T.I.3
Tjonneland, A.4
Vogel, U.5
-
20
-
-
35348876076
-
Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer
-
Vogel U, Christensen J, Dybdahl M, et al,. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 2007; 624: 88-100.
-
(2007)
Mutat Res
, vol.624
, pp. 88-100
-
-
Vogel, U.1
Christensen, J.2
Dybdahl, M.3
-
21
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
-
(2009)
PLoS Med
, vol.6
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
22
-
-
57449105091
-
Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype
-
Siemes C, Visser LE, Coebergh JW, Hofman A, Uitterlinden AG, Stricker BH,. Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype. Curr Cancer Drug Targets 2008; 8: 753-64.
-
(2008)
Curr Cancer Drug Targets
, vol.8
, pp. 753-764
-
-
Siemes, C.1
Visser, L.E.2
Coebergh, J.W.3
Hofman, A.4
Uitterlinden, A.G.5
Stricker, B.H.6
-
23
-
-
84875755059
-
Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry
-
Jiang X, Castelao JE, Vandenberg D, et al,. Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PLoS ONE 2013; 8: e60464.
-
(2013)
PLoS ONE
, vol.8
-
-
Jiang, X.1
Castelao, J.E.2
Vandenberg, D.3
-
24
-
-
84862005049
-
Oxidative balance and colon and rectal cancer: Interaction of lifestyle factors and genes
-
Slattery ML, Lundgreen A, Welbourn B, Wolff RK, Corcoran C,. Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes. Mutat Res 2012; 734: 30-40.
-
(2012)
Mutat Res
, vol.734
, pp. 30-40
-
-
Slattery, M.L.1
Lundgreen, A.2
Welbourn, B.3
Wolff, R.K.4
Corcoran, C.5
-
25
-
-
84863766276
-
PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population
-
Daraei A, Salehi R, Mohamadhashem F,. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population. Mol Biol Rep 2012; 39: 5219-24.
-
(2012)
Mol Biol Rep
, vol.39
, pp. 5219-5224
-
-
Daraei, A.1
Salehi, R.2
Mohamadhashem, F.3
-
26
-
-
84884241711
-
Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia
-
Abbenhardt C, Poole EM, Kulmacz RJ, et al,. Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. Int J Mol Epidemiol Genet 2013; 4: 140-9.
-
(2013)
Int J Mol Epidemiol Genet
, vol.4
, pp. 140-149
-
-
Abbenhardt, C.1
Poole, E.M.2
Kulmacz, R.J.3
-
27
-
-
84889084275
-
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations
-
Makar KW, Poole EM, Resler AJ, et al,. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control 2013; 24: 2059-75.
-
(2013)
Cancer Causes Control
, vol.24
, pp. 2059-2075
-
-
Makar, K.W.1
Poole, E.M.2
Resler, A.J.3
-
28
-
-
84875058198
-
Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia
-
Kleinstein SE, Heath L, Makar KW, et al,. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosom Cancer 2013; 52: 437-49.
-
(2013)
Genes Chromosom Cancer
, vol.52
, pp. 437-449
-
-
Kleinstein, S.E.1
Heath, L.2
Makar, K.W.3
-
30
-
-
84872151457
-
IkappaBKbeta and NFkappaB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry
-
Seufert BL, Poole EM, Whitton J, et al,. IkappaBKbeta and NFkappaB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2013; 34: 79-85.
-
(2013)
Carcinogenesis
, vol.34
, pp. 79-85
-
-
Seufert, B.L.1
Poole, E.M.2
Whitton, J.3
-
31
-
-
84879462177
-
TERT's role in colorectal carcinogenesis
-
Pellatt AJ, Wolff RK, Herrick J, Lundgreen A, Slattery ML,. TERT's role in colorectal carcinogenesis. Mol Carcinog 2013; 52: 507-13.
-
(2013)
Mol Carcinog
, vol.52
, pp. 507-513
-
-
Pellatt, A.J.1
Wolff, R.K.2
Herrick, J.3
Lundgreen, A.4
Slattery, M.L.5
-
32
-
-
84872607437
-
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer
-
Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL, Wolff RK,. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog 2013; 52: 155-66.
-
(2013)
Mol Carcinog
, vol.52
, pp. 155-166
-
-
Slattery, M.L.1
Lundgreen, A.2
Kadlubar, S.A.3
Bondurant, K.L.4
Wolff, R.K.5
-
33
-
-
84859920121
-
Toll-like receptor genes and their association with colon and rectal cancer development and prognosis
-
Slattery ML, Herrick JS, Bondurant KL, Wolff RK,. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer 2012; 130: 2974-80.
-
(2012)
Int J Cancer
, vol.130
, pp. 2974-2980
-
-
Slattery, M.L.1
Herrick, J.S.2
Bondurant, K.L.3
Wolff, R.K.4
-
34
-
-
67650179528
-
No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk
-
Thompson CL, Plummer SJ, Merkulova A, et al,. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J Gastroenterol 2009; 15: 2240-4.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 2240-2244
-
-
Thompson, C.L.1
Plummer, S.J.2
Merkulova, A.3
-
35
-
-
42149181801
-
Transcription factor 7-like 2 polymorphism and colon cancer
-
Slattery ML, Folsom AR, Wolff R, Herrick J, Caan BJ, Potter JD,. Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 978-82.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 978-982
-
-
Slattery, M.L.1
Folsom, A.R.2
Wolff, R.3
Herrick, J.4
Caan, B.J.5
Potter, J.D.6
-
36
-
-
39649089581
-
Leptin and leptin receptor genotypes and colon cancer: Gene-gene and gene-lifestyle interactions
-
Slattery ML, Wolff RK, Herrick J, Caan BJ, Potter JD,. Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer 2008; 122: 1611-7.
-
(2008)
Int J Cancer
, vol.122
, pp. 1611-1617
-
-
Slattery, M.L.1
Wolff, R.K.2
Herrick, J.3
Caan, B.J.4
Potter, J.D.5
-
37
-
-
34848905684
-
IL6 genotypes and colon and rectal cancer
-
Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD,. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007; 18: 1095-105.
-
(2007)
Cancer Causes Control
, vol.18
, pp. 1095-1105
-
-
Slattery, M.L.1
Wolff, R.K.2
Herrick, J.S.3
Caan, B.J.4
Potter, J.D.5
-
38
-
-
34447332275
-
Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: Evidence for gene-environment interaction?
-
Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J,. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction? Pharmacogenet Genomics 2007; 17: 639-45.
-
(2007)
Pharmacogenet Genomics
, vol.17
, pp. 639-645
-
-
Tan, X.L.1
Nieters, A.2
Hoffmeister, M.3
Beckmann, L.4
Brenner, H.5
Chang-Claude, J.6
-
39
-
-
33745596805
-
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
-
Samowitz WS, Wolff RK, Curtin K, et al,. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol 2006; 4: 894-901.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 894-901
-
-
Samowitz, W.S.1
Wolff, R.K.2
Curtin, K.3
-
40
-
-
32944469771
-
COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States)
-
Sansbury LB, Millikan RC, Schroeder JC, et al,. COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States). Cancer Causes Control 2006; 17: 257-66.
-
(2006)
Cancer Causes Control
, vol.17
, pp. 257-266
-
-
Sansbury, L.B.1
Millikan, R.C.2
Schroeder, J.C.3
-
41
-
-
32944454770
-
PPARgamma and colon and rectal cancer: Associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States)
-
Slattery ML, Curtin K, Wolff R, et al,. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control 2006; 17: 239-49.
-
(2006)
Cancer Causes Control
, vol.17
, pp. 239-249
-
-
Slattery, M.L.1
Curtin, K.2
Wolff, R.3
-
42
-
-
25144438001
-
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma
-
McGreavey LE, Turner F, Smith G, et al,. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma. Pharmacogenet Genomics 2005; 15: 713-21.
-
(2005)
Pharmacogenet Genomics
, vol.15
, pp. 713-721
-
-
McGreavey, L.E.1
Turner, F.2
Smith, G.3
-
43
-
-
22244433143
-
The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland
-
Macarthur M, Sharp L, Hold GL, Little J, El-Omar EM,. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev 2005; 14: 1613-8.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1613-1618
-
-
Macarthur, M.1
Sharp, L.2
Hold, G.L.3
Little, J.4
El-Omar, E.M.5
-
44
-
-
0036847568
-
Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia
-
Lin HJ, Lakkides KM, Keku TO, et al,. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2002; 11: 1305-15.
-
(2002)
Cancer Epidemiol Biomarkers Prev
, vol.11
, pp. 1305-1315
-
-
Lin, H.J.1
Lakkides, K.M.2
Keku, T.O.3
-
45
-
-
3843102713
-
Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
-
Cox DG, Pontes C, Guino E, et al,. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer 2004; 91: 339-43.
-
(2004)
Br J Cancer
, vol.91
, pp. 339-343
-
-
Cox, D.G.1
Pontes, C.2
Guino, E.3
-
46
-
-
84891449924
-
Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983267, and Colorectal Cancer According to CTNNB1 Alterations
-
Nan H, Morikawa T, Suuriniemi M, et al,. Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983267, and Colorectal Cancer According to CTNNB1 Alterations. J Natl Cancer Inst. 2013; 105: 1852-61.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 1852-1861
-
-
Nan, H.1
Morikawa, T.2
Suuriniemi, M.3
-
47
-
-
79951951693
-
Heme oxygenase-1 polymorphism is not associated with risk of colorectal cancer: A Danish prospective study
-
Andersen V, Christensen J, Overvad K, Tjønneland A, Vogel U,. Heme oxygenase-1 polymorphism is not associated with risk of colorectal cancer: a Danish prospective study. Eur J Gastroenterol Hepatol 2011; 23: 282-5.
-
(2011)
Eur J Gastroenterol Hepatol
, vol.23
, pp. 282-285
-
-
Andersen, V.1
Christensen, J.2
Overvad, K.3
Tjønneland, A.4
Vogel, U.5
-
48
-
-
84897522332
-
The effect ofUGT1AandUGT2Bpolymorphisms on colorectal cancer risk: Haplotype associations and gene-environment interactions
-
Angstadt AY, Hartman TJ, Lesko SM, et al,. The effect ofUGT1AandUGT2Bpolymorphisms on colorectal cancer risk: Haplotype associations and gene-environment interactions. Genes Chromosom Cancer 2014; 53: 454-66.
-
(2014)
Genes Chromosom Cancer
, vol.53
, pp. 454-466
-
-
Angstadt, A.Y.1
Hartman, T.J.2
Lesko, S.M.3
-
49
-
-
84873132350
-
Mammalian P4-ATPases and ABC transporters and their role in phospholipid transport
-
Coleman JA, Quazi F, Molday RS,. Mammalian P4-ATPases and ABC transporters and their role in phospholipid transport. Biochim Biophys Acta 2013; 1831: 555-74.
-
(2013)
Biochim Biophys Acta
, vol.1831
, pp. 555-574
-
-
Coleman, J.A.1
Quazi, F.2
Molday, R.S.3
-
51
-
-
80755166682
-
Lipid transport by mammalian ABC proteins
-
Quazi F, Molday RS,. Lipid transport by mammalian ABC proteins. Essays Biochem 2011; 50: 265-90.
-
(2011)
Essays Biochem
, vol.50
, pp. 265-290
-
-
Quazi, F.1
Molday, R.S.2
-
53
-
-
84875221424
-
The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer
-
Takatsuno Y, Mimori K, Yamamoto K, et al,. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer. Ann Surg Oncol 2013; 20: 1395-402.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 1395-1402
-
-
Takatsuno, Y.1
Mimori, K.2
Yamamoto, K.3
-
54
-
-
52549105588
-
Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk
-
Hazra A, Fuchs CS, Chan AT, Giovannucci EL, Hunter DJ,. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk. Cancer Causes Control 2008; 19: 975-80.
-
(2008)
Cancer Causes Control
, vol.19
, pp. 975-980
-
-
Hazra, A.1
Fuchs, C.S.2
Chan, A.T.3
Giovannucci, E.L.4
Hunter, D.J.5
-
55
-
-
84878248779
-
Dlg5 interacts with the TGF-beta receptor and promotes its degradation
-
Sezaki T, Tomiyama L, Kimura Y, Ueda K, Kioka N,. Dlg5 interacts with the TGF-beta receptor and promotes its degradation. FEBS Lett 2013; 587: 1624-9.
-
(2013)
FEBS Lett
, vol.587
, pp. 1624-1629
-
-
Sezaki, T.1
Tomiyama, L.2
Kimura, Y.3
Ueda, K.4
Kioka, N.5
-
56
-
-
84889023629
-
An inflammatory mediator, prostaglandin E2, in colorectal cancer
-
Wang D, DuBois RN,. An inflammatory mediator, prostaglandin E2, in colorectal cancer. Cancer J 2013; 19: 502-10.
-
(2013)
Cancer J
, vol.19
, pp. 502-510
-
-
Wang, D.1
Dubois, R.N.2
-
57
-
-
0027993458
-
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
-
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN,. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-8.
-
(1994)
Gastroenterology
, vol.107
, pp. 1183-1188
-
-
Eberhart, C.E.1
Coffey, R.J.2
Radhika, A.3
Giardiello, F.M.4
Ferrenbach, S.5
Dubois, R.N.6
-
58
-
-
33947533150
-
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the U.S. Preventive Services Task Force
-
Rostom A, Dube C, Lewin G, et al,. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 146: 376-89.
-
(2007)
Ann Intern Med
, vol.146
, pp. 376-389
-
-
Rostom, A.1
Dube, C.2
Lewin, G.3
-
59
-
-
81555222627
-
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention
-
Fischer SM, Hawk ET, Lubet RA,. Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila) 2011; 4: 1728-35.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 1728-1735
-
-
Fischer, S.M.1
Hawk, E.T.2
Lubet, R.A.3
-
60
-
-
79952460646
-
Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study
-
Andersen V, Nimmo E, Krarup HB, et al,. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study. Inflamm Bowel Dis 2011; 17: 937-46.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 937-946
-
-
Andersen, V.1
Nimmo, E.2
Krarup, H.B.3
-
63
-
-
0347949510
-
Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: A role for p50
-
Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ,. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 2004; 135: 64-73.
-
(2004)
Clin Exp Immunol
, vol.135
, pp. 64-73
-
-
Driessler, F.1
Venstrom, K.2
Sabat, R.3
Asadullah, K.4
Schottelius, A.J.5
-
64
-
-
0031017238
-
An investigation of polymorphism in the interleukin-10 gene promoter
-
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV,. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
-
(1997)
Eur J Immunogenet
, vol.24
, pp. 1-8
-
-
Turner, D.M.1
Williams, D.M.2
Sankaran, D.3
Lazarus, M.4
Sinnott, P.J.5
Hutchinson, I.V.6
-
65
-
-
18144383553
-
IL-12 and IL-10 polymorphisms and their effects on cytokine production
-
Yilmaz V, Yentur SP, Saruhan-Direskeneli G,. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30: 188-94.
-
(2005)
Cytokine
, vol.30
, pp. 188-194
-
-
Yilmaz, V.1
Yentur, S.P.2
Saruhan-Direskeneli, G.3
-
66
-
-
0033031984
-
Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis
-
Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P,. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-8.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 1101-1108
-
-
Crawley, E.1
Kay, R.2
Sillibourne, J.3
Patel, P.4
Hutchinson, I.5
Woo, P.6
-
67
-
-
21444450527
-
Low-dose aspirin in the primary prevention of cancer: The Women's Health Study: A randomized controlled trial
-
Cook NR, Lee IM, Gaziano JM, et al,. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 47-55.
-
(2005)
JAMA
, vol.294
, pp. 47-55
-
-
Cook, N.R.1
Lee, I.M.2
Gaziano, J.M.3
-
68
-
-
0027161914
-
Low-dose aspirin and incidence of colorectal tumors in a randomized trial
-
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH,. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993; 85: 1220-4.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1220-1224
-
-
Gann, P.H.1
Manson, J.E.2
Glynn, R.J.3
Buring, J.E.4
Hennekens, C.H.5
-
69
-
-
0032542897
-
What's wrong with Bonferroni adjustments
-
Perneger TV,. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-8.
-
(1998)
BMJ
, vol.316
, pp. 1236-1238
-
-
Perneger, T.V.1
-
70
-
-
79960059582
-
Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort
-
Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ,. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011; 106: 1340-50.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 1340-1350
-
-
Ruder, E.H.1
Laiyemo, A.O.2
Graubard, B.I.3
Hollenbeck, A.R.4
Schatzkin, A.5
Cross, A.J.6
-
71
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM, Wilson M, Elwin CE, et al,. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741-50.
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
|